Ranolazine as Antiarrhythmic Agent
Journal Title: BMH Medical Journal - Year 2019, Vol 6, Issue 2
Abstract
Ranolazine which has been approved for use an anti-anginal agent has been shown to have anti-arrhythmic properties both in experimental and clinical studies. Several case studies have shown the use of ranolazine in the treatment of atrial fibrillation, some even as a ‘pill in the pocket’ approach. MERLIN-TIMI 36, a randomized study of acute coronary syndrome, showed lower incidence of ventricular arrhythmias in the ranolazine arm. The most important anti-arrhythmic mechanism of of ranolazine is thought to be mediated by atrial-selective inhibition of peak sodium current (INaL) and inhibition of late INa in both atria and ventricles. The recent reclassification of anti-arrhythmic agents has designated drugs with this action in Class Id. There is clinical and experimental evidence for the potential use of ranolazine in congenital long QT syndrome 3. The recent RAID trial, a randomized evaluation of ranolazine in high risk patients with implantable cardioverter defibrillator and either ischemic or non-ischemic cardiomyopathy showed a marginally significant reduction of recurrent ventricular tachycardia and fibrillation. The potential risk of ranolazine-induced torsade de pointes in view of mild prolongation of QT interval has not been well confirmed, with only a single case report suggesting possible association. But the patient had other confounding factors including treatment with fluoxetine, amiodarone and diuretics causing hypokalemia and hypomagnesemia which are well known to cause torsade de pointes.
Authors and Affiliations
Johnson Francis, Charles Antzelevitch
Keywords
Related Articles
- EP ID EP647507
- DOI -
- Views 109
- Downloads 0
Paediatric Ambulatory Surgery
The International Association for Ambulatory Surgery (IAAS) defined Ambulatory surgery in 1995 as a ‟surgical or diagnostic interventions, currently performed with traditional hospitalisation, that could, in most cases,...
Endovascular Treatment For Acute Anterior Circulation Ischemic Stroke - New Evidence And Current Status
Endovascular mechanical treatment can remove large proximal clots rapidly and result in higher rates of reperfusion than IV rt-PA alone. Three initial trials of endovascular therapies in 2013 did not show a benefit for t...
Ebola Virus Disease
Ebola virus is named after the river in the former Zaire where a haemorrhagic fever initially identified in 1976 involved human to human transmission, as well as spread by contaminated injection equipments. Ebola virus c...
Revised Jones Criteria For The Diagnosis of Acute Rheumatic Fever (AHA 2015) - An Indian Perspective
Acute Rheumatic Fever (ARF) is still a major problem in some developing and low middle income countries though the incidence and prevalence has remarkably reduced in North America and Europe. Ever since T. Duckett Jon...
Device Closure of Small Ventricular Septal Defects: When and Why?
Ventricular septal defect (VSD) accounts for approximately 20-30 % of all forms of congenital heart disease (CHD). They were traditionally closed surgically in the past. The surgery though safe carries the risk of morbid...